Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients With Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
TH Open
doi 10.1055/s-0039-1692202
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Georg Thieme Verlag KG